417 - An Update on Convalescent Plasma for COVID-19

<p><span style="font-weight: 400;">Early in the pandemic, clinicians began to treat people sick with COVID-19 with the plasma of people who have recovered from COVID-19. The idea was that protective antibodies in the plasma would help prevent severe illness and death. Nearly two years later, the evidence is in—and it's being hotly debated. <strong>Dr. Arturo Casadevall</strong> returns to the podcast to talk with <strong>Dr. Josh Sharfstein</strong> about the results of the COVID-19 Plasma Project and his take on divergent recommendations about using plasma as a therapy.</span></p>